latest update:
[TrialBase DB]

trial summary · NCT06776939

Physiological Effect High-flow Tracheal Oxygen on Viscosity of Airway Mucus and Respiratory Effort in Patients Weaning From Invasive Mechanical Ventilation

Trial record from the TrialBase DB dataset, status RECRUITING, condition Weaning From Mechanical Ventilation, sponsored by Henrik Endeman. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06776939phase —enrollment 20start 2026-12-31

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Rationale: Tracheostomized patients weaning from mechanical ventilation are at risk for dryness of airway mucosa and sputum accumulation during disconnection from mechanical ventilation. High-flow tracheal oxygen (HFTO) is being used as supportive therapy during disconnection sessions in tracheostomized patients weaning from invasive mechanical ventilation (IMV) to limit dryness while maintaining oxygenation. We recently summarized the studies comparing physiological effects HFTO as compared to other interfaces, collectively referred to as conventional oxygen therapy (COT), in a systematic review and identified areas of lacking knowledge: effect on sputum viscoelasticity, respiratory effort early in the weaning process and dyspnea sensation. We hypothesize that HFTO, compared to COT, decreases viscoelasticity of the sputum and provides respiratory support during weaning. This may improve weaning by facilitating clearance of airway mucus, preventing respiratory failure, and providing comfort by decreasing dyspnea. Objective: To determine the physiological effect of HFTO compared to COT on sputum viscoelasticity, respiratory effort and dyspnoea. Study design: Pilot study with randomized crossover design, single-center. Study population: Twenty adult patients weaning from mechanical ventilation with tracheostomy. Intervention (if applicable): Crossover with COT and HFTO during two days in the weaning phase. Main study parameters/endpoints: Primary endpoint: sputum viscoelasticity measured by rheology during long disconnection sessions in the final phase of weaning. Secondary …

Source record: https://clinicaltrials.gov/study/NCT06776939

Facts

registry idNCT06776939
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionWeaning From Mechanical Ventilation
sponsorHenrik Endeman
sponsor classOTHER
enrollment20
start date2026-12-31
primary completion2026-12-31
completion2026-12-31
results postednot reported

Conditions

  • Weaning From Mechanical Ventilation
  • Tracheostomy Weaning
  • Respiratory Failure

Interventions

  • Oxygen therapy

Countries

  • Netherlands

Intervention types: DEVICE

Work with this record